On Jul. 24, 2026, Merck announced it has signed seven voluntary licensing agreements with generic drug manufacturers to…
On Jul. 19, 2026, Samsung Biologics announced the launch of an all-cash public tender offer to acquire 100%…
On Jul. 6, 2026, Novartis announced it has reached an agreement to acquire Myricx Bio for up to…
On Jun. 24, 2026, Antares Therapeutics announce it has entered a collaboration with Novartis that could be worth…
On Jun. 7, 2026, Roche announced that it has entered into an exclusive licensing and collaboration agreement with…
On Jun. 2, 2026, a research team from ETH Zurich and the University of Zurich (UZH) announced it…
On May 6, 2026, Swiss pharmaceutical giant Roche announced it had agreed to acquire U.S.-based digital pathology and…
On May 4, 2026, a study conducted by the University of Geneva and the Lausanne University Hospital (CHUV)…
On May 3, 2026, UCB, a global biopharmaceutical company, announced signing of a definitive agreement under which it…
On Mar. 27, 2026, Novartis announced an agreement to acquire Excellergy, a private biotech company developing next-generation anti-IgE…
On Mar. 20, 2026, Novartis announced an agreement with Synnovation Therapeutics, to acquire SNV4818, a pan-mutant‑selective PI3Kα inhibitor,…
On Feb. 24, 2026, The family of a Baltimore woman whose cells were extracted for medical research without…
On Feb. 6, 2026, Novartis broke ground on a new, state-of-the-art global Biomedical Research center in San Diego,…
On Jan. 9, 2026, Novartis announced plans to build its fourth US radioligand therapy (RLT) manufacturing facility in…
On Dec. 19, 2025, Novartis, a leading global innovative medicines company, announced it has reached an agreement with…
On Nov. 19, 2025, Novartis, a leading global innovative medicines company, announced plans to expand its operations in…
On Nov. 17, 2025, Sandoz announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by…
On Oct. 26, 2025, Novartis announced that it has entered into an agreement to acquire Avidity Biosciences, a…
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
On Sept. 9, 2025, Novartis announced that it has entered into an agreement to acquire Tourmaline Bio, a…
On Aug. 10, 2025, computer scientists at ETH Zurich announced they have developed a digital tool capable of…
On Jul. 28, 2025, as we mark World Hepatitis Day, the World Health Organization (WHO) calls on governments…
On Jul. 22, 2025, the World Health Organization (WHO) issued an urgent call for action on Tuesday to…
On May 12, 2025, Roche announced it plans to invest up to $550 million in its Diagnostics site…
On May 7, 2025, scientists reported that they have captured fungal spores cruising in the inhospitable environment of…
On Apr. 22, 2025, Roche announced that it will invest USD $50 billion into the United States in…
On Apr. 10, 2025, Novartis, a leading global innovative medicines company, announced a planned $23 billion investment over…
On Jul. 25, 2024, the World Health Organization (WHO) announced during the 25th International AIDS Conference, being held…
On Jul. 10, 2024, The World Health Organization (WHO) announced it had has prequalified the first hepatitis C…
On Jun. 10, 2024, Roche announced that the U.S. Food and Drug Administration (FDA) had granted Emergency Use…